Fulgent Genetics
FLGT
262 hedge funds and large institutions have $711M invested in Fulgent Genetics in 2022 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 85 increasing their positions, 81 reducing their positions, and 34 closing their positions.
17% more call options, than puts
Call options by funds: $58.8M | Put options by funds: $50.1M
1.94% more ownership
Funds ownership: 41% → 42.94% (+1.9%)
5% more repeat investments, than reductions
Existing positions increased: 85 | Existing positions reduced: 81
5% less funds holding
Funds holding: 275 → 262 (-13)
7% less capital invested
Capital invested by funds: $764M → $711M (-$53.2M)
21% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 34
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
+$21.3M |
| 2 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$20.9M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$8.96M |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$8.75M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$7.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AWA
Aaron Wealth Advisors
Chicago,
Illinois
|
-$17.5M |
| 2 |
Millennium Management
New York
|
-$12.7M |
| 3 |
NI
Nepsis Inc
Minneapolis,
Minnesota
|
-$7.01M |
| 4 |
Man Group
London,
United Kingdom
|
-$6.25M |
| 5 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
-$5.28M |
FLGT Hedge Fund Activity: Q2 2022 in Review
262 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q2 2022, worth a combined $711M — down 7% from $764M a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of FLGT and 27 opened new positions — a net loss of 7 holders — while 81 trimmed existing stakes and 85 added.
The largest buyer was Dimensional Fund Advisors, adding an estimated $21.3M. The largest seller was Aaron Wealth Advisors, cutting an estimated $17.5M.
- 262 institutional investors held Fulgent Genetics (FLGT) as of Q2 2022, down from 275 in Q1 2022.
- Funds reported $711M of Fulgent Genetics stock for Q2 2022, down 7% quarter-over-quarter.
- 27 funds opened new Fulgent Genetics positions in Q2 2022 and 34 closed out, a net change of -7 holders.
- The largest Fulgent Genetics buyer in Q2 2022 was Dimensional Fund Advisors, an estimated $21.3M added.
- The largest Fulgent Genetics seller in Q2 2022 was Aaron Wealth Advisors, an estimated $17.5M sold.
Based on aggregated 13F filings for Q2 2022.